Brief: Baxter Says Production Of Ifosfamide Resumed, But At Reduced Capacity That Does Not Meet Current Demand
24/03/2026 15:32
March 24 (Reuters) - Baxter International Inc BAX.N: BAXTER - PRODUCTION OF IFOSFAMIDE RESUMED, BUT AT REDUCED CAPACITY THAT DOES NOT MEET CURRENT DEMAND BAXTER - LIMITED SUPPLY OF IFOSFAMIDE WHICH WILL GRADUALLY IMPROVE THROUGH 2026 Further company coverage: BAX.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baxter International
See all newsS&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Press Digest: British Business - August 20
Brief: Baxter Appoints John Rogers Chief Financial Officer
Brief: Baxter Announces Pricing For Its Upsized Cash Tender Offers